Name: Author Interview: Professor Rüdiger Müller by The Immune-Mediated Inflammatory Disease Forum
Duration: 14 min 28 s
Description: Professor Rüdiger Müller, Rheumazentrum Ostschweiz, Switzerland. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Rüdiger Müller discusses his paper on the impact of switching tofacitinib dose in patients with RA.

Professor Rüdiger Müller, Rheumazentrum Ostschweiz, Switzerland. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Rüdiger Müller discusses his paper on the impact of switching tofacitinib dose in patients with RA.

Author Interview: Professor Rüdiger Müller

Iain McInnes discusses patient-reported outcomes. 
Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Discussing Rheumatology: Tofacitinib Improves PROs

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

Author Interview: Professor Rüdiger Müller

The Immune-Mediated Inflammatory Disease Forum

Related tracks